|
|
Effect of Methotrexate Combined with Uterine Artery Embolization on Uterine Curettage in Patients with Scar Pregnancy |
ZHANG Fu-e, LI Juan |
Department of Gynecology, Baoji People's Hospital, Baoji Shaanxi 721000 |
|
|
Abstract 【Objective】 To investigate the effect of methotrexate combined with uterine artery embolization on uterine curettage in patients with scar pregnancy.【Methods】 A total of 60 patients with scar pregnancy who were diagnosed and treated in Baoji people's Hospital of Shaanxi Province from March 2018 to may 2021 and planned to undergo uterine curettage were randomly divided into control group and observation group. The control group was pretreated with mifepristone combined with methotrexate before uterine curettage, and the observation group was pretreated with methotrexate combined with uterine artery embolization before uterine curettage. The amount of intraoperative bleeding, menstrual recovery time, serum human chorionic gonadotropin(β- HCG), sex hormone level and occurrence of adverse reactions of the two groups were compared. 【Results】 The amount of bleeding in the observation group was (75.62 ± 28.39) ml, which was significantly less than (106.57±34.86) mL in the control group (P<0.05). The operation time ,the negative time of β-HCG and the recovery time of menstruation were (25.18±5.34) min, (22.39±6.17) d and (38.35±5.76) d, respectively, which were shorter than those of the control group (33.75±7.29) min, (29.84±7.63) d and (49.56±6.84) d (P<0.05); At 1 and 3 months after operation, the levels of sex hormones in the two groups were lower than those before operation (P<0.05); Three months after operation, the levels of sex hormones in both groups were higher than that in one month after operation, and the change range of sex hormone levels in the observation group was smaller (P<0.05); The total incidence of adverse reactions in the observation group was 6.67%, which was lower than 30.00% in the control group (P<0.05).【Conclusion】Methotrexate combined with uterine artery embolization can reduce the bleeding volume of complete curettage of uterine cavity, shorten the time of β-HCG turning negative, promote the recovery of menstruation after operation, and have little effect on sex hormone level and low incidence of adverse reactions.
|
Received: 17 December 2021
|
|
|
|
|
[1] 韩娜, 王珊珊, 侯杉杉. 北京市通州区非选择性剖宫产的发生状况及影响因素分析[J].中国妇产科临床杂志, 2019, 20(1):72-73.
[2] 王燕. 急症产科患者分娩前后大出血原因研究[J].中国急救复苏与灾害医学杂志, 2020, 15(z1):75-76.
[3] CALÌ G, TIMOR-TRITSCH I E, PALACIOS-JARAQUEMADA J, et al. Outcome of Cesarean scar pregnancy managed expectantly:systematic review and meta-analysis[J].Ultrasound Obstet Gynecol,2018, 51(2):169-175.
[4] 胡路琴, 郑玉华, 袁惠芝, 等. 经阴道剖宫产瘢痕妊娠病灶切除术临床治疗效果分析[J].中国妇幼健康研究, 2019, 30(4):111-114.
[5] TAHAOGLU A E, DOGAN Y, BAKIR M S, et al. A single centre's experience of caesarean scar pregnancy and proposal of a management algorithm[J].J Obstet Gynaecol,2019, 39(2):259-264.
[6] 中华医学会妇产科学分会. 剖宫产术后子宫瘢痕妊娠诊治专家共识[J].中华妇产科杂志, 2016, 51(8):568-572.
[7] 李瑛, 罗军. 药物预处理与子宫动脉栓塞术对宫腔镜下清宫术治疗剖宫产瘢痕妊娠疗效的影响[J].国际妇产科学杂志, 2018, 45(4):401-404.
[8] 李荣, 卢余莉, 唐晖. 甲氨蝶呤联合子宫动脉栓塞术对剖宫产后瘢痕妊娠患者血-绒毛膜促性腺激素转阴时间、月经恢复时间及性激素的影响[J].中国药业, 2019, 28(23):37-39.
[9] 李洪滨, 程勇华, 李晓辉, 等. 子宫动脉栓塞术对剖宫产术后子宫瘢痕妊娠患者临床疗效及生育功能的影响[J].中国妇幼保健, 2018, 33(15):3488-3490.
[10] 王燕捷, 翟妍, 张震宇. 甲氨蝶呤联合子宫动脉栓塞术后定点吸胚术治疗剖宫产术后子宫瘢痕妊娠51例临床分析[J].国际妇产科学杂志, 2018, 45(2):150-154.
[11] 谭中宝, 毛学群, 王庆庆, 等.子宫动脉栓塞联合孕囊注射甲氨蝶呤序贯清宫术治疗瘢痕妊娠[J].介入放射学杂志, 2020, 29(1):96-99.
[12] 李高振, 高玉霞, 杨月华. 影响剖宫产瘢痕妊娠术中大出血发生的高危因素分析及风险预测模型构建[J].中国计划生育和妇产科, 2018, 10(10):32-36. |
|
|
|